Skip to main content
Clinical Trials/NCT05044260
NCT05044260
Unknown
Not Applicable

Evaluation of Direct Sinus Lift Using Ptfe Titanium Reinfored Membrane Assosiated With Immediate Implant Placement (Clinical Trial)

Hams Hamed Abdelrahman1 site in 1 country12 target enrollmentSeptember 1, 2020
ConditionsSinus Lift

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sinus Lift
Sponsor
Hams Hamed Abdelrahman
Enrollment
12
Locations
1
Primary Endpoint
Change in implant stability
Last Updated
4 years ago

Overview

Brief Summary

Various attempts have been implemented using different materials and techniques to augment the maxillary sinus floor enhancing autogenous bone formation to allow proper dental implant positioning. The aim of this study is to evaluate the sinus lift procedure using polytetrafluoroethylene (PTFE) titanium-reinforced membrane to maintain the space formed after Schneiderian membrane elevation followed by immediate implant placement.

Registry
clinicaltrials.gov
Start Date
September 1, 2020
End Date
October 20, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Hams Hamed Abdelrahman
Responsible Party
Sponsor Investigator
Principal Investigator

Hams Hamed Abdelrahman

Assistant lecturer of DPH and Clinical statistician

Alexandria University

Eligibility Criteria

Inclusion Criteria

  • Patients of both genders requiring implant placement in posterior maxilla
  • Age range: 40-60 years.
  • Good oral hygiene
  • Healthy maxillary sinus free from pathology
  • The minimum crestal bone height is (4-6) mm
  • Patients who are willing and fully capable to comply with the study protocol.

Exclusion Criteria

  • Sinus infection
  • Tumors or pathologic lesions in sinus
  • Severe allergic rhinitis.
  • Chronic topical steroid use.
  • Radiation therapy.
  • Psychologic / mental impairment
  • Acute infection (periodontitis or mucosal infection
  • Patients on radiotherapy or chemotherapy.
  • Alcohol or drug abuse.
  • Patient with systemic disorder (uncontrolled Diabetes mellitus, autoimmune diseases, bone diseases, etc.)

Outcomes

Primary Outcomes

Change in implant stability

Time Frame: at baseline and 6 months

It will be measured using Osstell

Change in bone density

Time Frame: at baseline and 6 months

It will be measured uisng CBCT on Demand 3d software

Change in bone formation

Time Frame: at baseline and 6 months

It will be measured uisng CBCT on Demand 3d software

Change in bone height

Time Frame: at baseline and 6 months

It will be measured uisng CBCT on Demand 3d software

Study Sites (1)

Loading locations...

Similar Trials